Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's Record History shows an added Revision: v3.3.2 and removal of Revision: v3.3.1, indicating a minor site release update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded entries for Study Status and Contacts/Locations, and updated the record revision to v3.3.1 (replacing the previous v3.2.0).SummaryDifference0.0%

- Check24 days agoChange DetectedThe only visible change is the removal of a site-wide notice about government funding status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedUpdated record history to include new Study Status and Contacts/Locations entries as of 2025-10-28/29, reflecting new status information and contact locations.SummaryDifference0.0%

- Check68 days agoChange DetectedUpdate to a newer revision identifier (v3.2.0) replaces the older v3.0.2.SummaryDifference0.0%

- Check69 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.